Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelliAM AI Regulatory News (INT.PL)

Share Price Information for IntelliAM AI (INT.PL)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
70.00
Ask:
90.00
Spread: 20.00 (28.571%)
Market Cap: £15.68m
INT.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday IntelliAM AI Share Chart

Manufacturing Tech Award 2025

12 Sep 2025 07:00

RNS Number : 0484Z
IntelliAM AI PLC
12 September 2025
 

 

12 September 2025

 

IntelliAM AI Plc

('IntelliAM' or the 'Company')

 

IntelliAM Wins Manufacturing Tech Company of the Year

 

IntelliAM AI plc (AQSE: INT), the software company leveraging the power of AI and machine learning in the manufacturing industry, announces that the Company has been named 'Manufacturing Tech Company of the Year' at the 2025 Business Tech Awards.

Tom Clayton, CEO of IntelliAM, commented:

"This industry recognition is a significant milestone for us. It reflects the hard work, innovation and dedication of our team, as well as the trust and support of our customers and partners.

 

"We are very proud to be helping manufacturers make the unknowable, knowable by turning machine data into transformational insights that boost productivity, cut downtime, and unlock new performance.

 

"We're also driving technology convergence - bringing together AI, machine learning and intelligent asset management - to accelerate digital change, push the boundaries of what is possible, and transform manufacturing for the future."

ends

 

Enquiries:

 

 

IntelliAM AI plc

Tom Clayton, Chief Executive Officer

Daud Khan, Chief Financial Officer

 

+44 114 299 5007

Oberon Capital - AQSE Corporate Adviser and Broker

Adam Pollock

Nick Lovering

Mike Seabrook

 

+44 203 179 5300

Square1 Consulting - Financial PR

David Bick

+44 207 929 5599

+44 7831 381201

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABFLLFEKLEBBE
12
Date   Source Headline
8th Jul 20267:00 amRNSNew Customer Wins
7th Jul 20267:07 amRNSFundraising to augment growth in US operations
6th Jul 20267:30 amRNSLaunch of Investor Hub
20th May 20267:00 amRNSUS Expansion and CRO Appointment
16th Apr 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSAcquisition of RBM Lubrications
19th Mar 20267:00 amRNSAppointment of Corporate Adviser and Broker
6th Jan 20267:00 amRNSOrders from New Customer in Frozen Food Vertical
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
10th Dec 20258:17 amRNSHolding(s) in Company
2nd Dec 20258:38 amRNSResult of Oversubscribed WRAP Retail Offer
25th Nov 20257:05 amRNSContract
25th Nov 20257:00 amRNSHalf-year Financial Report
24th Nov 202512:35 pmRNSWRAP Retail Offer
24th Nov 202512:30 pmRNSPlacing and Retail Offer
4th Nov 20257:00 amRNSFirst Half Trading Statement
27th Oct 20257:35 amRNSMove from Access to Apex segment
3rd Oct 20253:45 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSContract
24th Sep 20257:00 amRNSContract
12th Sep 20257:00 amRNS-RManufacturing Tech Award 2025
9th Sep 202512:33 pmRNSResult of Annual General Meeting
4th Sep 20257:00 amRNSDirectorate Change
12th Aug 20257:00 amRNSAnnual Financial Report
8th Aug 20253:00 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RAppointment of Vice President of Sales
7th Jul 20257:00 amRNSFinal Results
3rd Jul 20257:00 amRNSStrategic Partnership Agreement with CTC in USA
2nd Jul 20257:00 amRNSContract
1st Jul 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSTrading Update
2nd May 20257:00 amRNSDirectorate Change
26th Mar 20257:00 amRNS-RSenior Management Team Strengthened
20th Mar 20252:25 pmRNSDirector/PDMR Shareholding
24th Feb 20251:00 pmRNSDeath of a Non-Executive Director
13th Jan 20257:00 amRNSDirectorate Change
18th Dec 20243:57 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
12th Dec 20244:51 pmRNSDirector/PDMR Shareholding
11th Dec 20247:00 amRNSLetter of Intent Signed
9th Dec 20247:00 amRNSHalf-year Report
6th Nov 20241:13 pmRNSResult of Annual General Meeting
10th Oct 20243:30 pmRNSPosting of Annual Report and Notice of AGM
25th Sep 20247:00 amRNSAnnual Financial Report
16th Sep 20247:00 amRNSContract
7th Aug 20247:00 amRNSContract
11th Jul 20247:00 amRNSContract
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.